Recurrence risk in symptomatic intracranial stenosis treated medically in the real world

CONCLUSIONS: In patients with symptomatic ICAS, the real-world recurrence of ischemic events is higher than that seen in clinical trials, even in subgroups receiving the same pharmacological treatment strategies.PMID:37030126 | DOI:10.1016/j.jstrokecerebrovasdis.2023.107086

Source: Atherosclerosis - April 8, 2023 Category: Cardiology Authors: Shadi Yaghi Liqi Shu Eric D Goldstein Allison Chang Narendra Kala Christoph Stretz Tina M Burton Elizabeth Perelstein Karen Furie Mahesh Jayaraman Radhmer Torabi Krisztina Moldovan Adam de Havenon Pooja Khatri Mulugeta Gebregziabher David S Liebeskind Shy Source Type: research